Findings lay groundwork for human clinical trial planned for August 2016
A new scientific study has identified why colorectal cancer cells depend on a specific nutrient, and a way to starve them of it. Over one million men and women are living with colorectal cancer in the United States. The National Cancer Institute estimates 4.5% of all men and women will be diagnosed with the cancer during their lifetime, making it the third most common non-skin cancer.
In the study published online in Nature Communications, researchers showed how certain colorectal cancer cells reprogram their metabolism using glutamine, a non-essential amino acid. Many cancer cells rely on glutamine to survive. How they become so dependent on the molecule is hotly debated in the field.
Researchers studied a subset of colorectal cancer cells containing a genetic mutation called PIK3CA. This mutation is located in a gene critical for cell division and movement, and is found in approximately one third of all colorectal cancers. The mutation is also the most commonly identified genetic mutation across all cancers, making the results of the study universally appealing.
Researchers were interested in determining whether or not the common PIK3CA mutation contributes to changes in cancer cell metabolism, such as how nutrients like glutamine are processed. Normally, glutamine is broken down by cancer cells into several other molecules with the help of specific enzymes. This complicated system helps produce adenosine triphosphate, the energy currency of all cells, and other molecules critical for colorectal cancer cell growth.
The researchers found that colorectal cells with the PIK3CA mutation broke down significantly more glutamine than cells without the mutation. The researchers identified several enzymes involved in the process that are more active in the mutant cancer cells than in other cell types, explaining the increased need for glutamine. These enzymes become overactive in the mutant cancer cells due to a cascade of signals led by the protein encoded by mutant PIK3CA gene. This finding represents a novel and important link between the common PIK3CA mutation and altered glutamine metabolism in cancer cells.
Zhenghe John Wang, PhD, professor of genetics and genome sciences and co-leader of the Cancer Genetics Program at Case Western Reserve University School of Medicine helped lead the study. “In layman’s terms, we discovered that colon cancers with PIK3CA oncogenic mutations are addicted to glutamine, a particular nutrient for cancer cells. We also demonstrated that these cancers can be starved to death by depriving glutamine with drugs.”
When the researchers lowered the amount of glutamine available to mutant cancer cells growing in laboratory dishes, the cancer cells died. This discovery led the team to investigate the effects of blocking glutamine availability in mice with colorectal cancer tumors containing the common PIK3CA mutation. Wang and colleagues found that exposing these mice to a compound that blocks glutamine metabolism consistently suppressed tumor growth. They did not observe the same effect on tumors without the mutation. Together, these results provide a promising new therapeutic avenue to suppress growth of colorectal tumors with the PIK3CA mutation. The researchers have filed a patent application based on the unique mechanism of tumor suppression they have identified and the work is available for licensing.
“This study provides the basis for a colon cancer treatment clinical trial that will be started in the summer at the University Hospitals Seidman Cancer Center,” according to Neal Meropol, MD, Dr. Lester E. Coleman, Jr. Professor of Cancer Research and Therapeutics, chief of the division of hematology and oncology, and principal investigator for the trial. The phase I/II study will test the effects of a glutamine metabolism inhibitor in patients with advanced colorectal tumors.
The Latest on: Colorectal cancers
via Google News
The Latest on: Colorectal cancers
- Weight loss could be a risk factor for early-onset colorectal canceron June 25, 2019 at 7:26 am
SAN DIEGO — Male sex and advanced age are both risk factors for the development of early-onset colorectal cancer, according to results of a case-control study presented at Digestive Disease Week. ... […]
- Quiz Time: What Food May Offer Protection Against Colorectal Cancer?on June 22, 2019 at 2:04 pm
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up can be a challenge. As an aid for ... […]
- Colon cancer: Could yogurt prevent precancerous growths?on June 22, 2019 at 3:28 am
New observational research indicates an association between a lower risk of precancerous growths (adenoma) in the bowel and yogurt consumption patterns — in men, at least. Estimates from the National ... […]
- Expression of UPR effector proteins ATF6 and XBP1 reduce colorectal cancer cell proliferation and stemness by activating PERK signalingon June 21, 2019 at 8:39 am
The unfolded protein response (UPR) acts through its downstream branches, PERK-eIF2α signaling, IRE1α-XBP1 signaling and ATF6 signaling. In the intestine, activation of the UPR through the kinase PERK ... […]
- Colorectal Cancer Alliance Opens Young-Onset Colorectal Cancer Surveyon June 20, 2019 at 5:16 pm
Washington, D.C., June 20, 2019 (GLOBE NEWSWIRE) -- National nonprofit Colorectal Cancer Alliance is calling on allies to participate in its fourth annual survey of young-onset colorectal cancer ... […]
- Yogurt: Prophylaxis for Colorectal Cancer?on June 20, 2019 at 9:12 am
In the ongoing quest to identify risk modifiers for colorectal adenomas and cancer, a new study has found that men who consumed at least two weekly servings of yogurt had lower rates of conventional ... […]
- Colon cancer may be metastatic long before initial detectionon June 19, 2019 at 5:33 am
In most patients with metastatic colon cancer, the disease may have begun spreading throughout the body very early on -- when the original tumor was no bigger than a poppy seed, a new study suggests. ... […]
- Colorectal Cancer, Explained in Under Two MInuteson June 17, 2019 at 1:34 pm
Colorectal cancer may not get as much attention as lung cancer or breast cancer, but it’s actually the third most common type of cancer in both men and women, according to the American Cancer Society. ... […]
- Some Colorectal Cancers Are "Born To Be Bad," Have Already Spread Long Before Diagnosison June 17, 2019 at 8:18 am
Four out of five metastatic colorectal cancers have already spread before they are even diagnosed, according to new research out today, led by researchers at Stanford University. The study published ... […]
- Most metastatic colorectal cancers have spread before diagnosis, researchers sayon June 17, 2019 at 8:08 am
Up to 80% of metastatic colorectal cancers are likely to have spread to distant locations in the body before the original tumor has exceeded the size of a poppy seed, according to a study of ... […]
via Bing News